A major advance in cancer research is arising with the use of nanobodies to restore dysfunctional p53. This vital tumor inhibitor protein is frequently inactivated in several forms of cancer, leading uncontrolled https://linkingbookmark.com/story21835747/mini-antibodies-restore-tumor-suppressor-p53-a-new-pathway-for-malignant-therapy